Literature DB >> 27726180

Oral lichen planus associated with candidiasis during secukinumab treatment.

Takaya Komori1, Tetsuya Honda1, Yuichiro Endo1, Yo Kaku1, Atsushi Otsuka1, Kenji Kabashima1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27726180     DOI： 10.1111/1346-8138.13637

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  3 in total

1.  Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab).

Authors:  Bruna Lavinas Sayed Picciani; Arkadiusz Dziedzic; Juliana Tristão Werneck; Marcello Alves Marinho; Thaylla Núñez Amin Dick; Nara Regina Quintanilha; Eliane Pedra Dias
Journal:  BMC Oral Health       Date:  2021-06-08       Impact factor: 2.757

2.  Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?

Authors:  Tania Marusia Capusan; María Herrero-Moyano; Constanza Romina Martínez-Mera; Al Walid Freih-Fraih; Esteban Dauden
Journal:  JAAD Case Rep       Date:  2018-06-02

3.  Oral Candida Infection in Psoriatic Patients Treated with IL17A Inhibitors: Report of 3 Cases and a Comprehensive Review of the Literature.

Authors:  Efstathios Pettas; Vasiliki Savva; Vasileios Ionas Theofilou; Maria Georgaki; Nikolaos G Nikitakis
Journal:  Diagnostics (Basel)       Date:  2021-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.